Value Sense
HIMS
Hims & Hers Health, Inc. (HIMS)
Last Price$40.7(9.8%)
Market Cap$9,261.6M
Intrinsic value score
7/10
Great
Intrinsic value
$22.2
DCF value - N/A Relative value - $22.2
Overvalued
45.4%
LTM P/E
73.5x
Peer set median 35.3x
Discount rate
9.0%
HIMS
is 45.4% overvalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

HIMS Intrinsic value

Key Highlights:
Relative Value vs Current Share Price
As of Mar 03, 2025 HIMS Relative Value is $23.2, which is overvalued by 43.1%, compared to current share price of $40.7.
DCF Value vs Current Share Price
As of Mar 03, 2025 HIMS DCF Value is N/A, which is undervalued by N/A, compared to current share price of $40.7.
Methodology
Price per share, $
HIMS
Intrinsic value$22.2
Overvalued by45.4%
Current share price
40.7
Relative value
23.2
DCF value
not available

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

HIMS Historical Intrinsic Value

Crunching data... Almost there!

HIMS vs Peer Set: Intrinsic Value Comparison

General

Intrinsic Value

Financials

Company name

Undervaluation/Overvaluation

Revenue growth

EPS growth

Net income margin

Hims & Hers Health, Inc. logo
Hims & Hers Health, Inc.HIMS
(45.4%)
65.5%
(65.6%)
(2.7%)
Median Peer Set
2.1%
(4.3%)
10.2%
Church & Dwight Co., Inc. logo
Church & Dwight Co., Inc.CHD
(28.8%)
4.1%
(22.7%)
9.6%
The Clorox Company logo
The Clorox CompanyCLX
(24.8%)
(4.0%)
86.0%
3.9%
The Procter & Gamble Company logo
The Procter & Gamble CompanyPG
(22.6%)
2.5%
3.8%
17.7%
Kenvue Inc. logo
Kenvue Inc.KVUE
(11.3%)
0.1%
(40.0%)
6.7%
Colgate-Palmolive Company logo
Colgate-Palmolive CompanyCL
(10.2%)
3.3%
27.0%
14.4%
e.l.f. Beauty, Inc. logo
e.l.f. Beauty, Inc.ELF
0.4%
76.9%
99.1%
12.5%
Kimberly-Clark Corporation logo
Kimberly-Clark CorporationKMB
11.6%
(1.8%)
45.5%
12.7%
The Estée Lauder Companies Inc. logo
The Estée Lauder Companies Inc.EL
33.4%
(1.9%)
(61.2%)
2.5%
Unilever PLC logo
Unilever PLCUL
57.2%
1.8%
(12.4%)
10.9%
Coty Inc. logo
Coty Inc.COTY
182.3%
10.2%
(85.0%)
1.5%

Explore more intrinsic value tools hub for HIMS

DCF value calculator
Reverse DCF
Peter Lynch charts
Relative Value
Earnings growth model
Peter Lynch Fair Value
Margin of safety
Ben Graham Fair Value
Earnings Power Value
Discount rate

FAQ

What is Hims & Hers Health, Inc. intrinsic value?

As of Mar 03, 2025, Hims & Hers Health, Inc. Intrinsic Value is $22.2. This suggests it may be overvalued by 45.4% compared to its current price of around $40.7.

What is Hims & Hers Health, Inc. DCF (discounted cash flow) valuation?

As of Mar 03, 2025, Hims & Hers Health, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at N/A. This suggests it may be overvalued by N/A to its current price of around $40.7, using a discount rate of 9.0% and terminal growth rate of 2.0%.

Is Hims & Hers Health, Inc. overvalued or undervalued?

Hims & Hers Health, Inc. is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $22.2, compared to a market price of around $40.7. This suggests a potential overvaluation of 45.4%.